Cat.#: ACPP-1257
| Despition | MC4 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
| ACPP-1703 | Human PITPNA Protein (AC1703) | 5 µg | inquiry |
| ACPP-1394 | Human BPNT1 Protein (AC1394) | 2 µg | inquiry |
| ACPP-1784 | Human GPI Protein (AC1784) | 5 µg | inquiry |
| ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1255 | MC3 Receptor Blocking Peptide (AC1255) | 250 µg | inquiry |
| ACPP-1705 | Human NXPH1 Protein (AC1705) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.